Bioassay-Guided Fractionation, Pharmacognostic Standardization, And Mechanistic Pharmacological Evaluation Of Novel Phytochemicals
International Journal of Drug Delivery Technology · 13.05.2026 · 16 (27s)
DOI: 10.25258/ijddt.16.27s.86 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 13.05.2026. Verfasst von Vinod R. Patil und 6 weiteren Autor:innen.
Abstract (Originalsprache)
The present study focused on bioassay-guided fractionation, pharmacognostic standardization, and mechanistic pharmacological evaluation of novel phytochemicals from a medicinal plant to identify biologically active fractions and determine their therapeutic potential. Using hydroalcoholic solvent (70% ethanol), crude plant extract was fractionated into n-hexane, chloroform, ethyl acetate, and aqueous fractions. Pharmacognostic standardization included who-recommended macroscopic, microscopic, physicochemical, and phytochemical investigations. Bioassay-guided screening used in vitro antioxidant (dpph, abts) and anti-inflammatory (protein denaturation inhibition) tests. The most active fraction was tested for in vivo pharmacological efficacy in wistar albino rats (n = 6 per group). Mechanistic investigations estimated oxidative stress indicators (mda, sod, cat, gsh) and proinflammatory cytokines (tnf-α, il-6). Pharmacognostic analysis showed diagnostic markers such as 6.42 ± 0.21% total ash, 1.18 ± 0.09% acid-insoluble ash, and extractive values of 12.35 ± 0.34% (alcohol-soluble) and 9.27 ± 0.28% (water-soluble). Flavonoids, alkaloids, phenolics, and terpenoids were found in preliminary phytochemical screening. Among fractions, ethyl acetate had the highest antioxidant activity (42.6 ± 1.8 µg/ml (dpph) and 38.9 ± 2.1 µg/ml (abts)) compared to ascorbic acid (21.4 ± 1.2 µg/ml). In vivo tests showed considerable (p < 0.01) reduction in inflammatory markers, including tnf-α (from 82.4 ± 3.6 pg/ml to 41.7 ± 2.9 pg/ml) and il-6 (from 76.2 ± 3.1 to 35.8 ± 2.5 pg/ml). Oxidative stress markers improved significantly: mda reduced from 5.62 ± 0.41 to 2.31 ± 0.27 nmol/mg protein, while sod, cat, and gsh rose by 48.3%, 44.7%, and 52.6%, respectively. Histopathological study confirmed biochemical findings of reduced tissue damage and inflammation. Researchers found bioactive phytochemical fractions with strong antioxidant and anti-inflammatory properties. The ethyl acetate fraction had significant pharmacological effects, possibly by modulating oxidative stress and inflammation. These findings demonstrate the therapeutic potential of isolated phytochemicals and provide a solid foundation for medication development.
Zitieren
APA
Patil, V. R., Nikam, A. P., Newadkar, P. T., Ahire, T. A., Ahmed, Y. A. H. R., Wagh, P. S., & Bhamare, V. G. (2026). Bioassay-Guided Fractionation, Pharmacognostic Standardization, And Mechanistic Pharmacological Evaluation Of Novel Phytochemicals. International Journal of Drug Delivery Technology, 16(27s). https://doi.org/10.25258/ijddt.16.27s.86
Vancouver
Patil VR, Nikam AP, Newadkar PT, Ahire TA, Ahmed YAHR, Wagh PS, et al. Bioassay-Guided Fractionation, Pharmacognostic Standardization, And Mechanistic Pharmacological Evaluation Of Novel Phytochemicals. International Journal of Drug Delivery Technology. 2026;16(27s). doi:10.25258/ijddt.16.27s.86
BibTeX
@article{Patil2026,
author = {Patil, Vinod R. and Nikam, Aarti P. and Newadkar, Priti T. and Ahire, Tejaswini A. and Ahmed, Yunusi Aafaque Husain Riyaz and Wagh, Pallavi S. and Bhamare, Vaibhav G.},
title = {Bioassay-Guided Fractionation, Pharmacognostic Standardization, And Mechanistic Pharmacological Evaluation Of Novel Phytochemicals},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {27s},
doi = {10.25258/ijddt.16.27s.86}
}
EUVIMED